About Breast Cancer 2023

The 3^rd International Conference on Breast Cancer and Research 2023 holds immense value as it emphasizes the significance of breast cancer awareness, prevention, and treatment in promoting women's well-being. We recognize the importance of the collective effort to combat breast cancer and strive for improved outcomes.

Addressing the theme of Diagnostic and Therapeutic Advancements in Breast Cancer is of utmost importance at this conference. We acknowledge the rapid changes taking place in technology, legislation, and healthcare delivery, which directly impact the public health response to breast cancer. By exploring the potential of therapy and its implications for the future of breast cancer care, we can stay at the forefront of advancements in this field.

We are committed to providing a platform for academicians, researchers, scientists, industrial professionals, and students to share their valuable research work. Through this conference, we aim to create a forum for effective idea-sharing and collaboration, addressing future global challenges in breast cancer from the perspective of emerging trends in women's healthcare.

Great Reasons to Attend Breast Cancer 2023:

1. Stay updated on the latest research and advancements in breast cancer, improving patient care and outcomes.
2. Foster global communication and collaboration, connecting with diverse professionals to address breast cancer challenges.
3. Expand your professional network with like-minded individuals in breast cancer research and advocacy.
4. Gain new skills and knowledge through expert-led workshops and seminars for impactful contributions to breast cancer care.
5. Embrace recognition and awards, showcasing innovative work and inspiring further advancements.
6. Explore innovative products and services related to breast cancer care and support.
7. Gain diverse perspectives from speakers with varied backgrounds, expanding your understanding of breast cancer management and survivorship.

Important Scientific Sessions:

Track 1: Precision Oncology

The scientific session on precision oncology focuses on the field of cancer research and treatment that employs a personalized approach based on an individual's unique genetic and molecular characteristics. The session aims to delve into the various aspects of precision oncology, including its principles, methodologies, applications, and impact on cancer care.

Track 2: Oncology Nursing

The scientific session on oncology nursing focuses on the specialized field of nursing dedicated to the care of individuals diagnosed with cancer. The session aims to explore various aspects of oncology nursing, including its role in cancer care, the unique challenges and responsibilities faced by oncology nurses, and advancements in nursing practices to improve patient outcomes.

Track 3: Medical Oncology

The scientific session on medical oncology centers around the branch of medicine specializing in the diagnosis, treatment, and management of cancer using systemic therapies such as chemotherapy, targeted therapies, and immunotherapies. The session aims to explore various aspects of medical oncology, including current treatment strategies, emerging therapies, and advancements in the field.

Track 4: Breast Pathology

The scientific session on breast pathology focuses on the study and understanding of the pathological characteristics, diagnosis, and classification of breast diseases, including both benign and malignant conditions. The session aims to explore various aspects of breast pathology, including histopathological evaluation, molecular markers, diagnostic techniques, and emerging trends in the field.

Track 5: Types of Breast Cancers

The scientific session on types of breast cancers focuses on the classification, characteristics, and subtypes of breast cancer. The session aims to explore the different types of breast cancers, including their histological, molecular, and clinical features, and discuss their implications for diagnosis, treatment, and patient outcomes.

Track 6: Metastatic Breast Cancer

The scientific session on metastatic breast cancer focuses on the advanced stage of breast cancer where cancer cells have spread from the breast to other parts of the body, such as the bones, liver, lungs, or brain. The session aims to explore various aspects of metastatic breast cancer, including its biology, clinical management, treatment options, and quality of life considerations.

Track 7: Premenopausal Early Breast Cancer

The scientific session on premenopausal early breast cancer focuses on the diagnosis, treatment, and management of breast cancer in women who have not yet reached menopause. The session aims to explore various aspects of premenopausal early breast cancer, including its unique characteristics, treatment considerations, and long-term outcomes.

Track 8: Stages in Breast Cancer

The scientific session topic "Stages in Breast Cancer" focuses on understanding and classifying the different stages of breast cancer based on its progression and spread. Breast cancer is typically staged to determine the extent of the disease, guide treatment decisions, and predict prognosis.

Track 9: Male Breast Cancer Research

The scientific session on male breast cancer research focuses on the study and investigation of breast cancer specifically in men. The session aims to explore various aspects of male breast cancer, including its epidemiology, risk factors, biology, treatment approaches, and survivorship considerations.

Track 10: Health Disparities in Breast Cancer

The scientific session on health disparities in breast cancer focuses on understanding and addressing the unequal burden of breast cancer among different populations. The session aims to explore various aspects related to health disparities in breast cancer, including disparities in incidence, mortality, access to healthcare, treatment outcomes, and socioeconomic factors.

Track 11: Novel Drug Delivery Systems

The scientific session on novel drug delivery systems focuses on the development and advancements in drug delivery technologies for the treatment of various diseases, including cancer. The session explores innovative approaches and strategies to improve the targeted delivery, efficacy, and safety of therapeutic agents.

Track 12: Breast Cancer & Pregnancy

The scientific session on breast cancer and pregnancy focuses on the unique challenges and considerations in diagnosing, treating, and managing breast cancer in pregnant women. The session aims to explore various aspects related to breast cancer occurring during pregnancy, including its impact on maternal and fetal health, treatment options, and long-term outcomes.

Track 13: Tumor Cell Biology

The scientific session on tumor cell biology focuses on the study of the biological characteristics, behavior, and molecular mechanisms underlying tumor cells. The session aims to explore various aspects of tumor cell biology, including cellular processes, genetic and epigenetic alterations, tumor microenvironment interactions, and therapeutic implications.

Track 14: Genetics of Breast Cancer

The scientific session on the genetics of breast cancer focuses on understanding the genetic factors that contribute to the development and progression of breast cancer. The session aims to explore various aspects related to the genetic basis of breast cancer, including hereditary breast cancer syndromes, genetic risk factors, genetic testing, and implications for diagnosis, treatment, and prevention.

Track 15: Risk factors of Breast Cancer

The scientific session on risk factors of breast cancer focuses on identifying and understanding the various factors that contribute to an individual's risk of developing breast cancer. The session aims to explore different aspects related to breast cancer risk, including both non-modifiable and modifiable risk factors, their interactions, and their implications for prevention, early detection, and personalized interventions.

Track 16: Role of Circulating Tumor Cells

The scientific session on the role of circulating tumor cells focuses on the study of circulating tumor cells (CTCs) and their significance in cancer diagnosis, prognosis, treatment monitoring, and research. The session aims to explore various aspects related to CTCs, including their detection methods, molecular characterization, clinical implications, and potential as biomarkers for cancer management.

Track 17: Role of MicroRNA in Development and Progression

The scientific session on the role of microRNA in the development and progression of circulating tumor cells (CTCs) focuses on understanding the regulatory role of microRNA molecules in CTC biology, specifically their involvement in CTC development, dissemination, survival, and metastasis. The session aims to explore the molecular mechanisms underlying microRNA-mediated processes in CTCs and their potential as therapeutic targets or diagnostic markers.

Track 18: Role of the Tumor Microenvironment

The scientific session on the role of the tumor microenvironment focuses on understanding the complex interactions between cancer cells and their surrounding microenvironment, including the stromal cells, extracellular matrix, blood vessels, immune cells, and signaling molecules. The session aims to explore the influence of the tumor microenvironment on cancer initiation, progression, metastasis, treatment response, and resistance, as well as its potential as a therapeutic target.

Track 19: Breast Cancer Research

The scientific session on breast cancer research focuses on the investigation, advancements, and discoveries related to breast cancer, a complex and heterogeneous disease. The session aims to cover various aspects of breast cancer research, including epidemiology, risk factors, genetic factors, molecular biology, diagnosis, treatment strategies, and survivorship.

Track 20: Role of Epigenetics in Breast Cancer

The scientific session on the role of epigenetics in breast cancer focuses on understanding the influence of epigenetic modifications on breast cancer development, progression, and treatment response. The session aims to explore the epigenetic mechanisms involved in gene expression regulation, DNA methylation, histone modifications, and non-coding RNAs and their impact on breast cancer biology and clinical outcomes.

Track 21: Role of Artificial Intelligence in Breast Cancer

The scientific session on the role of artificial intelligence (AI) in breast cancer focuses on exploring the application of AI techniques, algorithms, and tools in various aspects of breast cancer research, diagnosis, treatment, and patient care. The session aims to discuss the potential benefits, challenges, and future directions of integrating AI into breast cancer management to enhance accuracy, efficiency, and personalized care

Track 22: Biomarkers for Early Detection of Breast Cancer

The scientific session on the role of artificial intelligence (AI) in breast cancer focuses on exploring the application of AI techniques, algorithms, and tools in various aspects of breast cancer research, diagnosis, treatment, and patient care. The session aims to discuss the potential benefits, challenges, and future directions of integrating AI into breast cancer management to enhance accuracy, efficiency, and personalized care.

Track 23: Personalized Risk Assessment Detection

The scientific session on personalized risk assessment detection in breast cancer focuses specifically on the identification and characterization of individualized risk factors and biomarkers to improve early detection and risk assessment of breast cancer. The session explores personalized approaches and strategies to assess an individual's risk of developing breast cancer and detect early signs of the disease.

Track 24: Advancements in Breast Cancer Imaging Technologies

The scientific session on advancements in breast cancer imaging technologies focuses on exploring the latest developments, innovations, and emerging techniques in the field of breast cancer imaging. The session aims to discuss the potential of these advancements in improving early detection, accurate diagnosis, treatment planning, and monitoring of breast cancer.

Track 25: Innovations in Breast Cancer Screening

The scientific session on innovations in breast cancer screening focuses on exploring the latest advancements, technologies, and strategies in the field of breast cancer screening. The session aims to discuss novel approaches, tools, and techniques that have the potential to improve the effectiveness, accessibility, and outcomes of breast cancer screening programs.

Track 26: Breast Surgery & Radiotherapy

The scientific session on breast surgery and radiotherapy focuses on discussing advancements, techniques, and research related to surgical interventions and radiotherapy in the management of breast cancer. The session aims to explore innovative approaches, surgical techniques, radiation therapy modalities, and their impact on improving outcomes and quality of life for breast cancer patients.

Track 27: Chemotherapy for Breast Cancer

The scientific session on chemotherapy for breast cancer focuses on discussing the role, advancements, and research related to chemotherapy in the treatment of breast cancer. The session aims to explore various aspects of chemotherapy, including its effectiveness, side effects, personalized approaches, and emerging therapies, to improve treatment outcomes and patient care.

Track 28: Advances in Radiation Therapy

The scientific session on advances in radiation therapy focuses on exploring the latest advancements, techniques, and research related to radiation therapy in cancer treatment. The session aims to discuss novel approaches, technologies, treatment planning strategies, and outcomes in radiation therapy, to improve treatment efficacy, precision, and patient outcomes

Track 29: Innovations in Breast Reconstruction Techniques

The scientific session on innovations in breast reconstruction techniques focuses on the latest advancements and novel approaches in reconstructive surgery for breast cancer patients. The session aims to explore emerging techniques, technologies, and research related to breast reconstruction to improve outcomes, aesthetics, and patient satisfaction.

Track 30: Role of Exercise in Breast Cancer

The scientific session on the role of exercise in breast cancer focuses on exploring the impact, benefits, and research related to exercise interventions in the prevention, treatment, and survivorship of breast cancer. The session aims to discuss the physiological, psychological, and social effects of exercise on breast cancer patients, to improve overall health, quality of life, treatment outcomes, and survivorship.

Track 31: Targeted Therapies for Breast Cancer

The scientific session on targeted therapies for breast cancer focuses on exploring the latest advancements, research, and clinical developments in the field of targeted therapies specifically designed for breast cancer treatment. The session aims to discuss the mechanisms of action, efficacy, safety, and future directions of targeted therapies, to improve treatment outcomes and personalize therapy for breast cancer patients.

Track 32: Predictive Biomarkers for Treatment Response

The scientific session on predictive biomarkers for treatment response focuses on identifying and exploring biomarkers that can predict the response to specific treatments in patients with various diseases, including cancer. The session aims to discuss the significance, discovery, validation, and clinical implementation of predictive biomarkers, to improve treatment outcomes and guide personalized therapeutic strategies.

Track 33: Liquid Biopsy for Monitoring Treatment Response

The scientific session on liquid biopsy for monitoring treatment response in breast cancer focuses on the use of liquid biopsy techniques to assess and monitor treatment response in breast cancer patients. Liquid biopsy refers to the analysis of various biomarkers, including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other molecular components present in the blood or other body fluids. Integrative Medicine Approaches for Breast Cancer Care

Track 34: Integrative Medicine approaches for breast cancer care

The scientific session on integrative medicine approaches for breast cancer care focuses on exploring the integration of complementary and alternative therapies alongside conventional medical treatments in the management of breast cancer. The session aims to discuss evidence-based integrative approaches that can enhance the overall well-being and quality of life of breast cancer patients. 

Track 35: Psychosocial Support and Survivorship Programs

The scientific session on integrative medicine approaches for breast cancer care focuses on exploring the integration of complementary and alternative therapies alongside conventional medical treatments in the management of breast cancer. The session aims to discuss evidence-based integrative approaches that can enhance the overall well-being and quality of life of breast cancer patients.

Track 36: Novel Therapies for Breast Cancer

The scientific session on novel therapies for breast cancer focuses on the exploration and presentation of innovative treatment approaches that have the potential to revolutionize the management of breast cancer. The session aims to discuss cutting-edge research and advancements in therapeutic strategies, with a specific focus on emerging therapies, experimental treatments, and breakthrough discoveries in the field of breast cancer.

Track 37: Survivorship Care Planning and Survivorship

The scientific session on survivorship care planning and survivorship focuses on addressing the unique needs and challenges faced by cancer survivors after completing their primary treatment. The session aims to explore strategies for providing comprehensive care to cancer survivors, including survivorship care planning, long-term follow-up, and support services to enhance their quality of life and overall well-being.

Track 38: Prognosis and Response Prediction

The scientific session on prognosis and response prediction focuses on predicting and assessing the prognosis (outcome) of patients with cancer and predicting their response to specific treatments. The session aims to explore various prognostic factors, predictive biomarkers, and innovative approaches that can aid in determining the likely course of disease and treatment response for individual patients.

Track 39: Quality of Life & Supportive Care

The scientific session on quality of life and supportive care focuses on addressing the multidimensional aspects of patients' well-being and providing comprehensive support throughout their cancer journey. The session aims to explore various strategies, interventions, and research related to improving the quality of life and providing supportive care services to individuals affected by cancer.

Track 40: De-escalation of Treatment:

The scientific session on de-escalation of treatment focuses on the concept of reducing the intensity or aggressiveness of treatment in certain cases of breast cancer. The session explores the potential benefits of de-escalation strategies in terms of minimizing treatment-related toxicities and side effects while maintaining optimal outcomes and quality of life for patients.

Target Audience:

1. Oncologists
2. Medical oncologists
3. Surgical oncologists
4. Radiation oncologists
5. Gynecologists
6. Breast surgeons
7. Plastic surgeons
8. Pathologists
9. Radiologists
10. Geneticists
11. Epidemiologists
12. Clinical researchers
13. Nurses specialized in oncology
14. Nurse practitioners
15. Patient advocates
16. Support group representatives
17. Representatives from breast cancer nonprofits
18. Pharmaceutical companies
19. Biotechnology companies
20. Medical device manufacturers
21. Policymakers in healthcare
22. Government representatives involved in breast cancer policy
23. Academics and researchers in the field of breast cancer
24. Educators in medical schools and universities
25. Breast cancer patients, survivors, and their caregivers

Market Analysis:

The breast cancer market is expected to grow positively from 2020 to 2023. The global healthcare market reached $855.9 billion in 2018, growing at a CAGR of 6.8% since 2014. It is projected to reach nearly $1,191.2 billion by 2022 with a CAGR of 8.6%.

In the nursing care market, healthcare facilities accounted for 43.6% of the market in 2018. The retirement communities segment is anticipated to have the highest growth rate with a projected CAGR of 9.7%. North America has the largest market share, followed by Western Europe and Asia-Pacific. The Middle East and Asia-Pacific are expected to be the fastest-growing regions.

The broader healthcare services market, including nursing care, was valued at $6,707.3 billion in 2018, growing at a CAGR of 7.6% since 2014. It is projected to reach approximately $9,581 billion by 2022 with a CAGR of 9.3%. Hospitals and clinics accounted for 55.1% of the market and experienced a CAGR of 8.2%.

Opportunities for growth in the breast cancer market can be found in the nursing care facilities segment, which is expected to generate $126.1 billion in annual sales by 2022. The United States presents the highest potential for market size expansion, with an estimated gain of $55.23 billion in the nursing care market.

Overall, the breast cancer market is expected to witness positive growth trends driven by factors such as increased healthcare spending, advancements in medical technology, and growing awareness of breast cancer. The market will continue to address challenges and opportunities in treatment, research, and care, supporting the growth of the global healthcare industry.